Anjana Srivatsan

Scopus Author ID ResearcherID ResearcherID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2020
Publications (10 Years): 3

Top Topics

Dna Damage Response

Saccharomyces Cerevisiae

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Nature communications

Ludwig Cancer Research

Baylor College of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Ludwig Cancer Research Jul 01 2017

United States

Research Scientist

Ludwig Institute for Cancer Research San Diego Branch - Jun 30 2017

United States

Postdoctoral Fellow :: Cancer Genetics

National Center for Biological Sciences

India

Junior Research Fellow :: Genetics

Indian Institute of Science

India

Junior Research Fellow :: Molecular Biophysics Unit

Education History

Baylor College of Medicine Aug 01 2003 - Apr 27 2010

United States

PHD :: Molecular and Human Genetics

Birla Institute of Technology and Science

India

MSC :: Biology

Publications

Elaine Guo, Yuki Ishii, James Mueller, Anjana Srivatsan, Timothy Gahman, Christopher D Putnam, Jean Y J Wang, Richard David Kolodner
FEN1 endonuclease as a therapeutic target for human cancers with defects in homologous recombination. Proceedings of the National Academy of Sciences of the United States of America 117 (32) (2020)
Rahul V Nene, Christopher D Putnam, Bin-Zhong Li, Katarina G Nguyen, Anjana Srivatsan, Christopher S Campbell, Arshad Desai, Richard David Kolodner
Cdc73 suppresses genome instability by mediating telomere homeostasis. PLoS genetics 14 (1) (2018)
Anjana Srivatsan, Bin-Zhong Li, Barnabas Szakal, Dana Branzei, Christopher D Putnam, Richard David Kolodner
The Swr1 chromatin-remodeling complex prevents genome instability induced by replication fork progression defects. Nature communications 9 (1) (2018)